By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tecan has licensed molecular diagnostics intellectual property from Enigma Diagnostics that it will use to pursue development of an integrated diagnostics solution with another partner.

The Swiss lab technologies developer said today that the license covers IP that is used in Enigma's automated point-of-care molecular diagnostic system, the Enigma ML.

Financial terms of the license agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.